Conferences  >  Medicine & Healthcare  >  Pharmacology and Drug Development  >  United Kingdom

Institute of Physics (IOP)

In order to be effective, a drug must be delivered to the right part of the body, at the correct time, and in an appropriate amount. If any one of these three criteria is not met, then a medicine will be ineffective or even dangerous. To develop potent medicines, pharmaceutical scientists need to find ways to enhance the intrinsic properties of drug molecules, for instance by increasing their solubility in water. There are a number of technologies which have been adopted to achieve these goals. One emerging approach which is attracting significant interest is electrospinning, which applies an electric field to generate nano-to-micro sized fibres from a polymer solution. Electrospun fibres have been very widely explored in the context of drug delivery.

Biomarkers 2024, designed to provide forward-looking insights into the latest trends and tools impacting biomarker research, it brings together leading experts from global pharmaceutical organisations, innovative biotech companies and internationally renowned academic institutions working across multiple therapeutic areas and stages of drug development.

Email: c.ashford@oxfordglobal.com

biomarkers, oncology, clinical development, neuroscience, NASH, biomarker technologies, digital pathologies

Royal Society of Chemistry (RSC)

The aim of the 8th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with this theme in having over three-quarters of the presentations focused on case studies. This will be complemented by technology progress in high concentration, NMR, SPR and X-ray screening.

Oxford Global

Connecting leaders in drug discovery to optimise organ modelling techniques and facilitate advanced applications 

Marketing Executive;     Email: m.blakey@oxfordglobal.com

Organ Modelling, Cell Culture, Mimics, Drug Development, Organ-on-a-Chip, Tissue-on-a-Chip, Organoids